Yüklüyor......
Novel Therapeutic Agents Against Cancer Stem Cells of Chronic Myeloid Leukemia
Chronic myeloid leukemia (CML) is induced by the BCR-ABL oncogene, a product of Philadelphia (Ph) chromosome. The BCR-ABL kinase inhibitor imatinib is a standard treatment for Ph(+) leukemia, and has been shown to induce a complete hematologic and cytogenetic response in most chronic phrase CML pati...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3136127/ https://ncbi.nlm.nih.gov/pubmed/20184539 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|